[1] Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza. Nat Rev Dis Primers 2018;4(1):3. https://www.nature.com/articles/s41572-018-0002-y.https://www.nature.com/articles/s41572-018-0002-y
[2] WHO. Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. https://www.who.int/en/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year. [2019-12-26].https://www.who.int/en/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year
[3] Liu WJ, Bi YH, Wang DY, Gao GF. On the centenary of the Spanish flu: being prepared for the next pandemic. Virol Sin 2018;33(6):463 – 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335225/.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335225/
[4] Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health 2013;103(3):e43 – 51. https://www.ncbi.nlm.nih.gov/pubmed/23327249.https://www.ncbi.nlm.nih.gov/pubmed/23327249
[5] McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004;78(23):12817 – 28. https://jvi.asm.org/content/78/23/12817.https://jvi.asm.org/content/78/23/12817
[6] Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990;175(1):59 – 68. https://www.sciencedirect.com/science/article/abs/pii/004268229090186U.https://www.sciencedirect.com/science/article/abs/pii/004268229090186U
[7] Tan SG, Zhang SH, Wu B, Zhao YZ, Zhang W, Han M, et al. Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans. Vaccine 2017;35(42):5644 – 52. https://www.sciencedirect.com/science/article/pii/S0264410X17311593?via%3Dihub.https://www.sciencedirect.com/science/article/pii/S0264410X17311593?via%3Dihub
[8] Quan CS, Wang QL, Zhang J, Zhao M, Dai QG, Huang T, et al. Avian influenza a viruses among occupationally exposed populations, China, 2014–2016. Emerg Infect Dis 2019;25(12):2215 – 25. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874249/.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874249/
[9] Qin L, Wang DY, Li DF, Zhao Y, Peng YC, Wellington D, et al. High level antibody response to pandemic influenza H1N1/09 virus is associated with interferon-induced transmembrane protein-3 rs12252-CC in young adults. Front Cell Infect Microbiol. 2018;8:134. https://www.ncbi.nlm.nih.gov/pubmed/29868492.https://www.ncbi.nlm.nih.gov/pubmed/29868492
[10] EMA. European Medicines Agency decision. http://www.docin.com/p-1460578024.html. [2020-03-23].http://www.docin.com/p-1460578024.html
[11] Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg 1972;70(4):767 – 77. https://www.ncbi.nlm.nih.gov/pubmed/4509641?dopt=Abstract.https://www.ncbi.nlm.nih.gov/pubmed/4509641?dopt=Abstract
[12] Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis 2014;14(12):1228 – 39. https://www.sciencedirect.com/science/article/abs/pii/S1473309914709600.https://www.sciencedirect.com/science/article/abs/pii/S1473309914709600
[13] Rondy M, Castilla J, Launay O, Costanzo S, Ezpeleta C, Galtier F, et al. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: results from the InNHOVE network. Hum Vaccin Immunother 2016;12(5):1217 – 24. https://www.tandfonline.com/doi/full/10.1080/21645515.2015.1126013.https://www.tandfonline.com/doi/full/10.1080/21645515.2015.1126013
[14] de Vries RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, Krammer F, Rimmelzwaan GF. Primary human influenza b virus infection induces cross-lineage hemagglutinin stalk-specific antibodies mediating antibody-dependent cellular cytoxicity. J Infect Dis 2017;217(1):3 – 11. https://academic.oup.com/jid/article/217/1/3/4773861.https://academic.oup.com/jid/article/217/1/3/4773861
[15] Ma MJ, Wang XX, Wu MN, Wang XJ, Bao CJ, Zhang HJ, et al. Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. Clin Microbiol Infect 2020;26(2):247-54. https://linkinghub.elsevier.com/retrieve/pii/S1198743X19303386.https://linkinghub.elsevier.com/retrieve/pii/S1198743X19303386